Coverage dated November 3, 2025 to November 5, 2025

Trump unveils deal to expand coverage and lower costs on obesity drugs

Headline from The Columbian, on the newest of 2 developments

WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

The Columbian's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

Nov 4, 2025
Trump administration nears deals for cheaper weight loss drugs with Novo Nordisk, Eli Lilly
Headline from STAT ·
Nov 6, 2025Newest
Trump unveils deal to expand coverage and lower costs on obesity drugs
Headline from The Columbian ·

Read the reports

Reports & sources

25 articles, oldest first.

FOX Business
Trump administration nearing deals with drugmakers on discounted weight loss medications: report (opens FOX Business)
Published Nov 3, 2025
FOX Business's feed description
Eli Lilly and Novo Nordisk are working with the Trump administration on a deal to cut weight loss drug costs to $149 monthly through the new TrumpRx initiative.
NBC News
The Trump administration is nearing a deal to lower prices for weight loss drugs (opens NBC News)
Published Nov 3, 2025
NBC News's feed description
The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of their weight loss drugs, a person familiar with the plan said.
STAT
Trump administration nears deals for cheaper weight loss drugs with Novo Nordisk, Eli Lilly (opens STAT)
Published Nov 3, 2025
STAT's feed description
Trump drug price negotiations expected to include Medicare coverage for weight loss drugs Wegovy, Zepbound, and prices as low as $150
CNN
Trump administration nears deals with pharmaceutical companies to offer obesity drugs for $149 a month (opens CNN)
Published Nov 3, 2025
CNN's feed description
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar with the negotiations.
Investor's Business Daily
Trump Slashes Obesity Drug Prices In Deal With Lilly, Novo (opens Investor's Business Daily)
Published Nov 5, 2025
Investor's Business Daily's feed description
The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss drugs.
The Columbian
Trump unveils deal to expand coverage and lower costs on obesity drugs (opens The Columbian)
Published Nov 5, 2025
The Columbian's feed description
WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
MedicalXpress
Trump unveils deals to lower costs of some weight-loss drugs (opens MedicalXpress)
Published Nov 5, 2025
MedicalXpress's feed description
US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs.
FOX Business
Trump announces deal with drugmakers to lower cost of weight-loss drugs (opens FOX Business)
Published Nov 5, 2025
FOX Business's feed description
Novo Nordisk and Eli Lilly finalized a deal with the Trump Administration to reduce costs of Wegovy and Zepbound weight-loss drugs through the new TrumpRx program.
CBS News
Trump to announce deal to lower weight loss drug prices in some cases (opens CBS News)
Published Nov 5, 2025
CBS News's feed description
The deal, with Eli Lilly and Novo Nordisk officials, is expected to lower the price of obesity drugs to $149 per month in certain cases, sources said.
NBC4 Washington
Trump strikes deal to lower cost of weight loss drugs (opens NBC4 Washington)
Published Nov 5, 2025
NBC4 Washington's feed description
Trump said his administration reached an agreement with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 weight loss drugs Wegovy and Zepbound.
New York Post
Trump to announce lower prices for weight-loss drugs, expanded Medicare eligibility (opens New York Post)
Published Nov 5, 2025
New York Post's feed description
Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, will agree to sell their drugs to Medicare at a lower "most favored nation" rate.
Al Jazeera
Weight-loss drug makers announce pricing agreement with Trump (opens Al Jazeera)
Published Nov 5, 2025
Al Jazeera's feed description
The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.
Blaze Media
Trump strikes major deal with pharma giants Lilly and Novo over obesity drugs, Medicare (opens Blaze Media)
Published Nov 5, 2025
Blaze Media's feed description
The administration recognizes that while GLP-1 weight-loss drugs aren't a 'silver bullet,' they're certainly a handy tool in the war against obesity.
The Guardian
Trump announces plan to cut cost of weight loss drugs and expand access (opens The Guardian)
Published Nov 5, 2025
The Guardian's feed description
Injectable versions of GLP-1s from Eli Lilly and Novo Nordisk will see reduced prices and broader coverage
The Daily Caller
Trump Announces Discounted Obesity Drugs (opens The Daily Caller)
Published Nov 5, 2025
The Daily Caller's feed description
President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and Novo Nordisk.
Forbes
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs (opens Forbes)
Published Nov 5, 2025
Forbes's feed description
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
Los Angeles Times
How will Trump's deal on weight-loss drugs affect prices? (opens Los Angeles Times)
Published Nov 5, 2025
Los Angeles Times's feed description
President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy
RedState
Trump Announces Weight-Loss Drug Deal With Pharma in WH Event Marked by Scary Medical Issue (opens RedState)
Published Nov 5, 2025
RedState's feed description
Trump strikes deal with Eli Lilly and Novo Nordisk to lower weight-loss drug prices.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.